MDCX Medicus Pharma Ltd. - Common Stock
MDCX Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
MDCX Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
MDCX Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
- Beli Kuat 2 20,0%
- Beli 7 70,0%
- Tahan 1 10,0%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
4 analis · 2026-08-14Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-0.31 | $-0.20 | -0.11% |
| 31 Des. 2025 | $-0.83 | $-0.16 | -0.67% |
| 30 Sep. 2025 | $-0.65 | $-0.30 | -0.35% |
| 30 Juni 2025 | $-0.42 | $-0.26 | -0.16% |
| 31 Maret 2025 | $-0.42 | $-0.24 | -0.18% |
| 31 Des. 2024 | $-0.18 | $-0.30 | 0.12% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| MDCX | — | — | — | — | — | — |
| PBM | — | — | — | — | — | — |
| XENE | $3.59B | -10.3 | — | -4612.1% | -56.9% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 12
| Metrik | Tren | Q1 2026 |
|---|---|---|
| R&D Expense | $3M | |
| SG&A Expense | $6M | |
| Operating Expenses | $9M | |
| Operating Income | $-9M | |
| Interest Expense | $374.7K | |
| Other Non-op | $-445.2K | |
| Net Income | $-9M | |
| EPS (Basic) | $-0.31 | |
| EPS (Diluted) | $-0.31 | |
| Shares (Basic) | 29,540,833 | |
| Shares (Diluted) | 29,540,833 | |
| EBITDA | $-9M |
Neraca 15
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $6M | |
| Prepaid Expense | $917.0K | |
| Current Assets | $7M | |
| Total Assets | $7M | |
| Accounts Payable | $2M | |
| Current Liabilities | $6M | |
| Capital Leases | $24.2K | |
| Total Liabilities | $6M | |
| Common Stock | $67M | |
| Paid-in Capital | $7M | |
| Retained Earnings | $-73M | |
| AOCI | $-190.5K | |
| Stockholders' Equity | $1M | |
| Liabilities + Equity | $7M | |
| Shares Outstanding | 39,995,463 |
Arus Kas 6
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Stock-based Comp | $599.3K | |
| Operating Cash Flow | $-9M | |
| Stock Issued | $0 | |
| Net Stock Activity | $0 | |
| Financing Cash Flow | $7M | |
| Net Change in Cash | $-2M |
Profitabilitas 2
| Metrik | Tren | Q1 2026 |
|---|---|---|
| ROA | -138.2% | |
| ROE | -520.6% |
Likuiditas & Solvabilitas 3
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Current Ratio | 1.2 | |
| Quick Ratio | 1.1 | |
| Interest Coverage | -22.9 |
Valuasi (TTM) 6
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Market Cap | $18M | |
| P/E | -0.2 | |
| P/B | 13.8 | |
| P / Tangible Book | 13.8 | |
| P / Cash Flow | -2.0 | |
| Earnings Yield | -496.7% |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 24 pengaju · $1.1M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 10 (+3 vs Kuartal sebelumnya) | 7 (0 vs Kuartal sebelumnya) | 6 (+1 vs Kuartal sebelumnya) | 4 (+1 vs Kuartal sebelumnya) | +259K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Interchange Capital Partners, LLC | $718.376 | 1.586.871 | 63,85% | Saham |
| XTX Topco Ltd | $108.612 | 243.362 | 9,65% | Saham |
| JANE STREET GROUP, LLC | $105.107 | 235.508 | 9,34% | Saham |
| Sterling Investment Advisors, Ltd. | $44.630 | 100.000 | 3,97% | Saham |
| COMMONWEALTH EQUITY SERVICES, LLC | $23.490 | 52.643 | 2,09% | Saham |
| May Hill Capital, LLC | $22.593 | 50.622 | 2,01% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.041 | 31.462 | 1,25% | Saham |
| STIFEL FINANCIAL CORP | $13.389 | 30.000 | 1,19% | Saham |
| JPMORGAN CHASE & CO | $12.498 | 25.622 | 1,11% | Saham |
| Wilmington Savings Fund Society, FSB | $11.435 | 25.622 | 1,02% | Saham |
| CITADEL ADVISORS LLC | $11.203 | 25.102 | 1,00% | Saham |
| Stratos Wealth Partners, LTD. | $9.350 | 20.950 | 0,83% | Saham |
| LPL Financial LLC | $7.816 | 17.512 | 0,69% | Saham |
| MARATHON CAPITAL MANAGEMENT | $6.918 | 15.500 | 0,61% | Saham |
| StoneX Group Inc. | $6.365 | 17.066 | 0,57% | Saham |
| Foundations Investment Advisors, LLC | $4.909 | 11.000 | 0,44% | Saham |
| OSAIC HOLDINGS, INC. | $3.375 | 7.500 | 0,30% | Saham |
| MORGAN STANLEY | $446 | 1.000 | 0,04% | Saham |
| MERCER GLOBAL ADVISORS INC /ADV | $223 | 500 | 0,02% | Saham |
| JONES FINANCIAL COMPANIES LLLP | $183 | 400 | 0,02% | Saham |
| WELLS FARGO & COMPANY/MN | $89 | 200 | 0,01% | Saham |
| Smithfield Trust Co | $11 | 24.614 | 0,00% | Saham |
| HAZLETT, BURT & WATSON, INC. | $0 | 425 | 0,00% | Saham |
| ROYAL BANK OF CANADA | $0 | 1.055 | 0,00% | Saham |
Orang dalam perusahaan 14 orang dalam · 6 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Raza Bokhari | Chief Executive Officer | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Carolyn F. Bonner | President and CFO | 3 Juni 2026 A | — | 0 | 0 | $0 |
| James P. Quinlan | Chief Financial Officer | 13 Agu 2025 M | 274.147 | 0 | 0 | $0 |
| Andrew Alasdair Smith | Chief Operating Officer | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Edward J. Brennan | Chief Scientific Officer | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Faisal Mehmud | Chief Medical Officer | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Cathy Mcmorris Rodgers | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Ajay Raju | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Sara R. May | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Larry Kaiser | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Robert J. Ciaruffoli | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Barry Fishman | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| William Ashton | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
| Patrick J Mahaffy | Direktur | 3 Juni 2026 A | — | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka